The Rosamund Stone Zander Translational Neuroscience Center strives to improve the lives of all children with brain disorders by fostering timely and efficient translational research.
Our Advocacy and Research Partners
For Patients
Research Services
Research Funding
Featured News & Events
IDEFINE commits $300,000 to launch natural history study of Kleefstra Syndrome with Boston Children's Hospital
IDefine – The Kleefstra Syndrome Foundation today announced a $300,000 grant to help launch a groundbreaking natural history study at Boston Children’s Hospital’s Rosamund Stone Zander Translational Neuroscience Center (RSZ TNC). The three-year study will advance critical research and help prepare the Kleefstra syndrome (KS) community for future clinical trials.
Novel Phenotypes and Genotype-Phenotype Correlations in Patients with Kleefstra Syndrome
A retrospective chart review performed on 65 patients with Kleefstra Syndrome evaluated at the BCH Kleefstra clinic uncovered novel phenotypes and genotype-phenotype correlations. This information may be useful for guiding clinical care and informing future research and therapeutic initiatives.
Rosamund Stone Zander Translational Neuroscience Center Selects Three Pilot Research Grant Awardees
The Rosamund Stone Zander Translational Neuroscience Center (RSZ TNC) at Boston Children’s Hospital is delighted to announce the selection of this year’s RSZ TNC Pilot Research Grant awardees. The mission of the RSZ TNC is to improve the lives of children with brain disorders via timely and efficient translation of scientific research through collaboration with Boston Children’s Hospital’s exceptional investigators, and in partnership with the external research community. To fulfill the goal of “timely and efficient translation,” this grant aims to support translational research on neurodevelopmental disorders within the domains of Preclinical Research, Drug Discovery, Therapeutic Development, Translational Biomarkers, and Gene-based Clinical Research and Trials.